Research Program Cardiovascular and Metabolic Diseases
Speaker: Prof. Dr. Thomas E. Willnow
Cardiovascular diseases are the most frequent cause of death in our society. In Germany alone, approximately 300,000 patients experience cardiac infarction per year, while 80,000 suffer from stroke. Furthermore, 20,000 Germans are treated for kidney failure every year. In terms of health care expenses cardiovascular related diseases occupy a top position amounting to 12.4 per cent share of the entire health budget. Because of the aging of our population, the significance of cardiovascular diseases for our health care system will even increase dramatically. Therefore, identifying the underlying causes of these diseases and developing new strategies for their treatment are a top priority of biomedical research in the Helmholtz Association of German Research Centres.
Clinical Research Programs
(Prof. Dr. Friedrich C. Luft)
Heart Disease
(Prof. Dr. Ludwig Thierfelder)
( Prof. Dr. Ludwig Thierfelder )
( Dr. Salim Seyfried )
( Prof. Dr. Harald Saumweber )
( Prof. Dr. Rainer Dietz )
( Prof. Dr. Thoralf Niendorf )
( Prof. Dr. Ingo Morano )
( Prof. Dr. Michael Gotthardt )
Hypertension Vascular Disease and Kidney Disease
(Prof. Dr. Thomas E. Willnow)
( Prof. Dr. Ferdinand le Noble )
( Prof. Kai Schmidt-Ott )
( Prof. Dr. Norbert Huebner )
( Prof. Dr. Friedrich C. Luft )
( Prof. Dr. Michael Bader )
( Prof. Dr. Thomas Willnow )
( Prof. Dr. Young-Ae Lee )
Metabolic Diseases, Genetics, Genomics and Bioinformatics
(Prof. Dr. Nikolaus Rajewsky)
( Prof. Dr. Jens Reich )
( Dr. Daniela Panakova )
( Prof. Dr. Mathias Treier )
( Dr. Baris Tursun )
( Prof. Dr. Matthias Selbach )
( Dr. Jana Wolf )
( Dr. Matthew Poy )
( Dr. Markus Landthaler )
( Dr. Zsuzsanna Izsvak )
( Dr. Francesca Spagnoli )
( Prof. Dr. Tobias Pischon )
( Prof. Dr. Thomas Jentsch )
( Dr. Alexander Loewer )
( Prof. Dr. Nikolaus Rajewsky )